课题基金 / 基金详情

Prevention and control of chronic and respiratory viral diseases using PapMV nanoparticles.

Prevention and control of chronic and respiratory viral diseases using PapMV nanoparticles.
使用 PapMV 纳米粒子预防和控制慢性和呼吸道病毒性疾病。
批准号:
278016
负责人:
Leclerc Denis
金额:
$55.39万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2013
资助国家:
加拿大
项目状态:
已结题
起止时间:
2013-03-01 至 2018-03-01

项目摘要

项目成果

Leclerc Denis的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have recently developed a novel adjuvant that is a rod-shape nanoparticle made of the coat protein of a plant virus assemble around a RNA. We showed that the nanoparticles are able to expand and increase significantly the immune response to the seasona
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Preclinical proof of concept studies of a new generation of TLR7/8 agonist used in prevention against respiratory viruses and in immunotherapy against lung cancer.
  • 批准号:
    473345
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2022
  • 负责人:
    Leclerc Denis
  • 依托单位:
COVID-19 Variant Supplement - Development of a nanoparticle-based vaccine candidate to the SARS-CoV-2
  • 批准号:
    443203
  • 项目类别:
    Operating Grants
  • 资助金额:
    $3.64万
  • 财政年份:
    2021
  • 负责人:
    Leclerc Denis
  • 依托单位:
Development of a nanoparticle-based vaccine candidate to the SARS-CoV-2
  • 批准号:
    422762
  • 项目类别:
    Operating Grants
  • 资助金额:
    $52.28万
  • 财政年份:
    2020
  • 负责人:
    Leclerc Denis
  • 依托单位:
Adjuvantization of SIV antigens using a novel toll like receptor 7 (TLR7) agonist: A proof of concept in non human primate.
  • 批准号:
    365665
  • 项目类别:
    Operating Grants
  • 资助金额:
    $18.21万
  • 财政年份:
    2017
  • 负责人:
    Leclerc Denis
  • 依托单位:
海外基金